Buscar
Mostrando ítems 1-10 de 12
The Falling Incidence of Hematologic Cancer After Heart Transplantation
(Wiley, 2014-10-01)
[Abstract] Background. A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the ...
Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: a preliminary report
(Via Médica, 2016)
[Abstract] Background: Ivabradine, a selective bradycardic drug, inhibits the If. In patients with heart failure (HF), ivabradine reduces the risk of rehospitalization and mortality. The average heart rate (HR) reduction ...
Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study
(Wiley, 2010-06-27)
[Abstract] The longer survival of patients with heart transplantation (HT) favors calcineurin inhibitor–related chronic kidney disease (CKD). It behoves to identify risk factors. At 14 Spanish centers, data on 1062 adult ...
Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value
(Elsevier, 2018-11-23)
[Abstract] Introduction and objectives: Circulating galectin-3 (Gal-3) is elevated and significantly correlates with all-cause and cardiovascular mortality in patients with heart failure. However, the relationship between ...
Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit
(Elsevier, 2020-01-21)
[Abstract] Introduction and objectives: To analyze survival in heart failure (HF) patients treated at a specialized unit.
Methods: Prospective cohort-based study of HF patients treated at a specialized unit from 2011 ...
Usefulness of the INTERMACS scale for predicting outcomes after urgent heart transplantation
(Elsevier, 2011)
[Abstract] Introduction and objectives. Our aim was to assess the prognostic value of the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) scale in patients undergoing urgent heart transplantation ...
Lung cancer after heart transplantation: results from a large multicenter registry
(Wiley, 2011-04-26)
[Abstract] In this study we analyzed Spanish Post-Heart-Transplant Tumour Registry data for adult heart transplantation (HT) patients since 1984. Median post-HT follow-up of 4357 patients was 6.7 years. Lung cancer (mainly ...
Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection
(Elsevier, 2017-07-15)
[Abstract] Background. Heart transplantation (HT) is a life-saving treatment for patients with end-stage heart failure. One of the main problems after HT is the humoral response termed antibody-mediated rejection (AMR). ...
AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients
(Stanislaw Stepkowski,, 2019-07-23)
[Abstract] Introduction.
One of the main problems involved in heart transplantation (HT) is antibody-mediated rejection
(AMR). Many aspects of AMR are still unresolved, including its etiology, diagnosis and
treatment. ...